HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Xiao-Feng Sun Selected Research

Histidine (L-Histidine)

11/2013PINCH expression in relation to radiation response in co-cultured colon cancer cells and in rectal cancer patients.
4/2012Histopathological classification of pseudomyxoma peritonei and the prognostic importance of PINCH protein.
1/2010PINCH protein expression in normal endometrium, atypical endometrial hyperplasia and endometrioid endometrial carcinoma.
1/2008PINCH expression and its significance in esophageal squamous cell carcinoma.
1/2007Expression of PINCH protein in gliomas and its clinicopathological significance.
1/2006Particularly interesting new cysteine-histidine rich protein expression in colorectal adenocarcinomas.
1/2006Clinicopathological significance of stromal variables: angiogenesis, lymphangiogenesis, inflammatory infiltration, MMP and PINCH in colorectal carcinomas.
12/2005Up-regulation of PINCH in the stroma of oral squamous cell carcinoma predicts nodal metastasis.
11/2004Stromal staining for PINCH is an independent prognostic indicator in colorectal cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Xiao-Feng Sun Research Topics

Disease

46Neoplasms (Cancer)
08/2015 - 07/2003
37Colorectal Neoplasms (Colorectal Cancer)
08/2015 - 01/2002
28Rectal Neoplasms (Rectal Cancer)
12/2014 - 09/2004
23Neoplasm Metastasis (Metastasis)
04/2014 - 01/2002
15Colonic Neoplasms (Colon Cancer)
08/2015 - 06/2008
8Adenocarcinoma
01/2012 - 07/2003
7Microsatellite Instability
08/2015 - 02/2002
4Adenoma (Adenomas)
08/2015 - 01/2008
3Necrosis
08/2006 - 03/2005
2Mucinous Adenocarcinoma (Mucinous Carcinoma)
01/2015 - 03/2005
2Infection
01/2015 - 04/2012
2Pancreatitis
01/2013 - 04/2010
2Urinary Bladder Neoplasms (Bladder Cancer)
08/2012 - 05/2012
2Stomach Neoplasms (Stomach Cancer)
01/2012 - 12/2004
2Iron Overload
08/2010 - 02/2009
2Breast Neoplasms (Breast Cancer)
10/2009 - 11/2005
2Melanoma (Melanoma, Malignant)
07/2008 - 07/2007
2Carcinoma (Carcinomatosis)
01/2007 - 08/2004
1Pulmonary Embolism
01/2015
1Gastrointestinal Neoplasms (Gastrointestinal Cancer)
03/2014
1Hyperalgesia
10/2013
1Neuralgia (Stump Neuralgia)
10/2013
1Pain (Aches)
10/2013
1Inflammation
01/2013
1Pseudomyxoma Peritonei
04/2012
1Chronic Hepatitis B
04/2012
1Sarcoma (Soft Tissue Sarcoma)
03/2011
1Cardiomegaly (Heart Hypertrophy)
08/2010
1Cardiomyopathies (Cardiomyopathy)
08/2010
1Neurodegenerative Diseases (Neurodegenerative Disease)
08/2010
1Lymphatic Metastasis
01/2010
1Hypertension (High Blood Pressure)
01/2010

Drug/Important Bio-Agent (IBA)

12Messenger RNA (mRNA)IBA
02/2012 - 07/2003
10Cysteine (L-Cysteine)FDA Link
04/2014 - 11/2004
9Histidine (L-Histidine)FDA Link
11/2013 - 11/2004
8Proteins (Proteins, Gene)IBA
01/2013 - 01/2006
7N-methylsuccinimideIBA
08/2015 - 07/2003
7Calcibiotic Root Canal SealerIBA
03/2014 - 01/2008
6Biological FactorsIBA
01/2013 - 01/2006
6DNA (Deoxyribonucleic Acid)IBA
08/2009 - 02/2002
5MicroRNAs (MicroRNA)IBA
08/2015 - 01/2009
5Fluorouracil (Carac)FDA LinkGeneric
01/2015 - 08/2004
4Biological Markers (Surrogate Marker)IBA
08/2015 - 07/2007
4ParaffinIBA
08/2014 - 01/2010
4Peroxisome Proliferator-Activated Receptors (PPAR)IBA
03/2014 - 02/2008
4N 30IBA
01/2012 - 11/2005
3Cyclooxygenase 2 (Cyclooxygenase-2)IBA
07/2006 - 04/2002
3tumor suppressor protein p73IBA
07/2006 - 01/2002
2Small Interfering RNA (siRNA)IBA
08/2015 - 04/2013
2Facilitative Glucose Transport Proteins (Glucose Transporter)IBA
08/2015 - 07/2011
2Leucovorin (Folinic Acid)FDA Link
01/2015 - 12/2004
2capecitabine (Xeloda)FDA Link
01/2015 - 03/2014
2Matrix Metalloproteinase 7 (Matrilysin)IBA
02/2014 - 01/2007
2Cisplatin (Platino)FDA LinkGeneric
04/2013 - 08/2012
2Caerulein (Ceruletide)IBA
01/2013 - 04/2010
2RNA (Ribonucleic Acid)IBA
01/2013 - 02/2012
2hydrogen sulfite (bisulfite)IBA
08/2012 - 05/2012
2Caspase 10IBA
12/2011 - 01/2008
2Mitochondrial DNA (mtDNA)IBA
08/2010 - 02/2009
2IronIBA
08/2010 - 02/2009
2Estrogens (Estrogen)FDA Link
01/2010 - 11/2005
2Codon (Codons)IBA
07/2008 - 01/2003
1Small Nucleolar RNA (snoRNA)IBA
08/2015
1bevacizumabFDA Link
01/2015
1oxaliplatin (Eloxatin)FDA LinkGeneric
01/2015
1P 569IBA
04/2014
1Carbon MonoxideIBA
11/2013
1Sirolimus (Rapamycin)FDA Link
10/2013
1Caspase 3 (Caspase-3)IBA
04/2013
1Toll-Like Receptors (Toll-Like Receptor)IBA
01/2013
1HormonesIBA
01/2013
1Tumor Suppressor Protein p14ARF (p14ARF)IBA
01/2013
1PPAR deltaIBA
01/2013
1interleukin-21 (interleukin 21)IBA
04/2012
1telbivudineFDA Link
04/2012
1Hepatitis B e AntigensIBA
04/2012
1Carrier Proteins (Binding Protein)IBA
02/2012
1Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA
03/2011
1dasatinib (BMS 354825)FDA Link
03/2011
1Complementary DNA (cDNA)IBA
01/2011
1Dextrans (Dextran)FDA Link
08/2010
1Toll-Like Receptor 4IBA
04/2010
1TNF Receptor-Associated Factor 6 (TRAF6)IBA
04/2010
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
04/2010
1Nuclear Pore Complex Proteins (Nucleoporins)IBA
01/2010
1Blood Glucose (Blood Sugar)IBA
01/2010
1DAPIIBA
01/2010
1Formaldehyde (Formol)FDA Link
01/2010
1indolepropanol phosphate (IPP)IBA
12/2009
1AntigensIBA
10/2009
1Biotin (Vitamin H)FDA Link
10/2009
1DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA
10/2009

Therapy/Procedure

21Radiotherapy
12/2014 - 09/2004
4Drug Therapy (Chemotherapy)
12/2014 - 08/2004
2Adjuvant Chemotherapy
12/2014 - 08/2004
1Heterologous Transplantation (Xenotransplantation)
05/2015
1Neoadjuvant Therapy
01/2015
1Spinal Injections
10/2013
1Injections
08/2010
1Intraperitoneal Injections
04/2010